Forum for Collaborative HIV Research – HCV Drug Resistance Slide Set
Recognizing the need for education regarding
HCV drug resistance, the Forum for Collaborative HIV Research's HCV
Drug Development Advisory Group (academicians, clinicians, researchers
and patient advocates) have contributed to a slide deck
explaining resistance in HCV, its consequences as well as its
mitigation. The slide deck explains important drug resistance concepts
in HCV, including:
This educational slide deck
is intended for use by a diverse audience ranging from health care
providers involved with evaluating, diagnosing and treating HCV, HCV
patients who want to learn about the disease and treatment options, and
HCV advocates in the community who may use the slides in their education
outreach efforts. For more information about the Forum, please visit: www.hivforum.org.
IDSA Guidelines Slide Sets
The practice guideline slide sets are available to the public for download. Some recommendations have been shortened or combined to clearly emphasize clinical points. If using this set, familiarity with the actual recommendations from the published document is highly recommended. You may use or present a slide set in its entirety if you credit the author and source of the material.
Slide Sets Available:
Uncomplicated Cystitis and Pyelonephritis (UTI)
For more information on our guidelines, please visit the IDSA Practice Guidelines page.
1300 Wilson Boulevard Suite 300 Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2017 Infectious Diseases Society of America